Prospect News: News for Catalent Pharma Solutions, Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with C > Issuers starting with C, HY only > All stories on Catalent Pharma Solutions, Inc. > Stories on Catalent Pharma Solutions, Inc., HY only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Catalent Pharma Solutions, Inc.

2/6/2024	BKHY	Moody’s eyes Catalent for upgrade
2/5/2024	HY	Market Commentary: Post Holdings, NOVA drive-by; Stena, Ardonagh on deck; Allied struggles; Catalent surges on takeover
12/14/2023	CLHY	Market Commentary: USI, Nuvei, Travel + Leisure, Summit, Catalent break; Davis, ArcLight updated
12/13/2023	CLHY	Market Commentary: Innio, Citadel, R1 RCM, A-Gas break; USI revised; Summit Behavioral, Catalent accelerated
12/11/2023	CLHY	Market Commentary: IntraFi sets final terms; Chobani accelerated; Castlelake, Playa and more disclose talk
12/11/2023	BKHY	Moody’s rates Catalent Pharma loan Ba2
12/11/2023	BKHY	S&P cuts loan, rates Catalent loan BB-
8/29/2023	HY	Market Commentary: JOLTS report jolts buyers in junk secondary; Catalent rises; Ford improves; Coinbase gains
6/26/2023	BKHY	Moody’s turns Catalent view to stable
6/8/2023	BKHY	Moody's downgrades Catalent
5/8/2023	HY	Market Commentary: Ball, Northern Oil and Gas drive-by; Heartland Dental flat; Catalent tumbles; DISH under pressure
4/17/2023	BKHY	Moody's eyes Catalent for downgrade
4/14/2023	HY	Market Commentary: Junk: Baytex at a premium; Spirit Aero ails on supply gaffe; Catalent down on profit warning
4/14/2023	HY	Market Commentary: Morning Commentary: Spirit AeroSystems notes shed altitude on gaff impacting Boeing
11/2/2021	BKBWHY	Catalent aims to de-lever naturally after raising $1.1 billion debt
9/23/2021	HY	New Issue: Catalent sells upsized $650 million 8.5-year notes at par to yield 3˝%
9/23/2021	BKHY	Moody's gives B1 to Catalent notes
9/23/2021	HY	Catalent to sell $450 million 8.5-year notes on Friday; initial talk high 3% area
9/23/2021	BKHY	S&P assigns Catalent notes BB-
8/31/2021	BKBWHY	Catalent CEO, CFO discuss plans for Bettera acquisition
2/10/2021	HY	New Issue: Catalent prices upsized $550 million 3 1/8% eight-year notes at par
2/10/2021	CLHY	Market Commentary: Ensemble Health, Ontic, Catalent break; Precision, Compassus, Cotiviti deal changes surface
2/10/2021	BKHY	Moody’s assigns B1 to Catalent’s notes
2/10/2021	BKHY	S&P gives Catalent notes BB-
11/18/2020	BKHY	Moody’s upgrades Catalent
4/23/2020	BKHY	S&P ups Catalent senior secured rating
4/16/2020	HY	Market Commentary: CDW, Hilton price; Change Healthcare adds on; Six Flags, Cleveland-Cliffs soar
3/25/2020	HY	Market Commentary: Secondary gains continue; Altice soars on earnings; HCA, TransDigm gain on stimulus package
3/13/2020	HY	Market Commentary: Secondary pares losses from unprecedented week; Altice mixed; HCA bid up
3/12/2020	HY	Market Commentary: Sell-off continues; TransDigm in focus; Uniti, Centene below par; funds lose $4.94 billion
3/12/2020	HY	Market Commentary: Morning Commentary: Junk searches for bid as markets flail and stocks trip breakers
2/28/2020	BKHY	Moody’s ups Catalent loans
2/20/2020	HY	New Issue: Catalent prices upsized €825 million 2 3/8% eight-year notes at par
2/20/2020	HY	Catalent launches upsized €825 million eight-year notes at 2 3/8%; pricing Thursday
2/20/2020	BKHY	Moody’s assigns Catalent notes B3
2/19/2020	HYLM	Catalent intends to fully redeem 4ľ% notes due 2024 via new offering
2/19/2020	BKHY	S&P rates Catalent Pharma notes B+
2/19/2020	HY	Catalent marketing €450 million eight-year notes; proceeds to take out 4ľ% notes due 2024
6/25/2019	HY	Market Commentary: New deal frenzy continues; primary prices $3.35 billion over six deals; Antero, William Lyon lag
6/25/2019	HY	Correction: Catalent Pharma Solutions prices $500 million eight-year notes at par to yield 5%
6/24/2019	HY	Market Commentary: Primary market prices $4.01 billion in seven deals; calendar grows; Michaels, Talen Energy weaken
6/24/2019	HY	New Issue: Catalent Pharma Solutions sells $500 million eight-year notes at par to yield 5 1/8%
6/24/2019	BKHY	Moody’s rates Catalent notes B3
6/24/2019	BKHY	S&P rates Catalent Pharma notes B+
6/24/2019	HY	Catalent Pharma driving by with $500 million eight-year notes; initial talk low 5% area
5/9/2019	CLHY	Market Commentary: Catalent Pharma, LightBox, ThoughtWorks break; Oryx Midstream, FirstLight revise deals
5/9/2019	BKHY	Moody's lowers Catalent, rates loan Ba3
4/29/2019	CLHY	Market Commentary: Kestra, NVA, Livingston, Sound Physicians free to trade; Flexera moves commitment deadline
8/6/2018	BKHY	Moody’s ups Catalent facility
10/16/2017	HY	Market Commentary: Pattonair prices; new Friday names busy; Ruby Tuesday jumps on buyout; hospitals steady after Friday drop
10/13/2017	HY	Market Commentary: UPC, Catalent, Vine price deals; new attack on ACA roils hospitals
10/13/2017	HY	New Issue: Catalent prices $450 million eight-year notes at par to yield 4 7/8%
10/12/2017	HY	Market Commentary: Tekni-Plex prices below talk; energy names droop with crude; funds gain $967 million
10/12/2017	HY	Catalent Pharma talks $450 million eight-year notes at 5% area yield; pricing Friday
10/11/2017	CLHY	Market Commentary: Dell Technologies launches $4.79 billion repricing; Beacon, Catalent, Fuller narrow terms
10/10/2017	HY	Market Commentary: Charter two-part, Targa drive by; new West, Parsley, PlastiPak deals busy; oil names push up, Neiman Marcus gains
10/10/2017	BKHY	Moody’s rates Catalent Pharma notes B3
10/10/2017	BKHY	S&P cuts Catalent debt, rates notes B+
10/10/2017	HY	Catalent Pharma starts roadshow for $450 million eight-year notes
10/4/2017	CLHY	Market Commentary: Camping World, Lighthouse Network break; Sterling Talent, VerticalScope update deal terms
10/3/2017	CLHY	Market Commentary: West breaks; Camping World, NCL, CPA Global updated; Duff & Phelps modifies deadline
12/2/2016	CLHY	Market Commentary: Albertsons, USIC, Save-A-Lot, Zebra, AdvancePierre break; Catalent, Quikrete changes emerge
11/28/2016	CLHY	Market Commentary: RevSpring breaks atop OID; CHG adjusts issue price; Zebra, Catalent launch repricings
11/28/2016	BKHY	Moody’s ups Catalent loans, rates notes B3
11/28/2016	BKHY	S&P assigns BB- to Catalent notes
11/24/2014	CLHY	Market Commentary: Catalent breaks; Hudson’s Bay weakens; Tibco, C&J, Packers, Global Cash, Equinox revised
11/21/2014	CLHY	Market Commentary: CareCore frees to trade; Catalent tweaks size, issue prices; Q Holdings reveals talk
11/20/2014	CLHY	Market Commentary: Creganna-Tactx, Navex break; B/E Aerospace, Parq, Tecomet, Camping World update deals
7/30/2014	HYLM	Catalent Pharma calls all $350 million 7 7/8% senior notes due 2018
7/24/2014	BKDDHY	S&P: Catalent Pharma on positive watch
4/30/2014	BKDDHY	S&P rates Catalent loan BB-
4/30/2014	BKHY	Moody's assigns Catalent loans Ba3
4/25/2013	BKHY	S&P rates Catalent loan B
3/8/2013	BKHY	Moody's: Catalent view negative
11/13/2012	HYLM	Catalent redeems $304.1 million notes after $45.9 million tendered
9/6/2012	HY	Market Commentary: Claire's, Starz, HudBay, HealthSouth price in $1.9 billion day; new bonds firm up; funds gain
9/5/2012	HY	New Issue: Catalent Pharma prices upsized $350 million notes due 2018 at par to yield 7 7/8%
9/5/2012	HY	Market Commentary: Upsized Digicel mega-deal leads $3 billion-plus primary, new Axles active, Starz on tap
9/5/2012	HYLM	Catalent Pharma lifts tender offer cap for 91/2%/101/4% PIK-election notes
9/5/2012	BKDDHY	Moody's: Catalent notes Caa1
9/4/2012	HY	Catalent Pharma to price $250 million six-year notes on Wednesday
9/4/2012	HY	Market Commentary: Axle, Rock-Tenn price; $3 billion more slates as post- holiday primary revives; ATP slide deepens
9/4/2012	HYLM	Catalent Pharma begins tender offer for 91/2%/101/4% PIK-election notes
4/25/2012	BKDDHY	S&P rates Catalent loan BB-
3/14/2012	HYLM	Catalent to redeem $5.27 million of 91/2%/101/4% senior PIK notes
3/7/2012	BKDDHY	Moody's: Catalent loan Ba3
2/16/2012	BKDDHY	S&P: Catalent unchanged
11/16/2011	BKDDHY	Moody's confirms Catalent, view up to stable
8/25/2011	BKHY	S&P: Catalent unchanged
8/23/2011	BKDDHY	Moody's may cut Catalent
12/17/2010	BKDDHY	Moody's ups Catalent to SGL-2
4/13/2010	HY	Catalent to make October interest payment on toggle notes in cash
12/3/2009	HY	Moody's: Catalent outlook negative
4/6/2009	HY	Catalent picks PIK option for October interest payment on toggle notes

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.